Now enrolling for April 2012
Click here to request an application form.
Special Announcement!
Hibernia College’s Master of Science in Pharmaceutical Medicine has been recognised as the world’s first IMI Pharmatrain Centre of Excellence, recognising that our students receive the highest quality education available in medicines development . For more information about the Innovative Medicines Initiative Pharmatrain project visit www.pharmatrain.eu
Programme Overview
This online masters degree is designed for professionals working in the pharmaceutical industry who wish to open up new career opportunities by gaining a greater understanding of scientific and economic factors affecting a drugs life cycle from molecule to market place.
It is suitable for professionals including physicians, scientists and managers working in the pharmaceutical and biotechnology industries. Our students come from areas such as project management, clinical research, clinical trial management, medical affairs, regulatory affairs, data management, drug safety, marketing and pharmacoeconomics, engineering, validation and operations.
The programme provides a systematic understanding of the drug development process from initial discovery through research and development to the regulatory approval process and commercialisation. The programme enables students to design and manage major projects, critically evaluate data and lead multidisciplinary teams. Students gain valuable business and management expertise required for senior positions in the pharmaceutical industry and many of our graduates have been promoted to Vice President level in drug development, quality management, medical affairs and scientific advisory boards within their organisations.
Key Information
- Accreditation: HETAC
- Recognition: IFAPP
- Next intake: April 2012
- Duration: 2 years taught + thesis
- Total Tuition Fees: €18,000*
* The above fees are subject to change.
The Innovative Medicines Initiative and PharmaTrain
The Innovative Medicines Initiative (IMI) is a unique partnership between the European Community and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Its aim is to support the faster discovery and development of better medicines for patients and to enhance Europe’s competitiveness by ensuring that its biopharmaceutical sector remains a dynamic high-technology sector.
Hibernia College is a member of the European Federation of Courses in Pharmaceutical Medicine, which in partnership with IFAPP, has won the IMI call 16 (Pharmatrain) tender. PharmaTrain is a training programme that aims to provide a comprehensive solution for the training needs of integrated drug development for all professionals involved in the industry.
This broad-based programme will greatly enhance the skill-sets and competencies of all key contributors to the drug development and regulatory processes using the latest scientific approaches in the development of medicines on pathophysiology, safety and risk-awareness, patient and population-based benefit as well as make the development process faster, more economical and more competitive.
For more information on the IMI and PharmaTrain click here.
Accreditation and links
The current programme is accredited by HETAC to Level 9 on the National Framework of Qualifications (to see a diagram explaining the National Framework of Qualifications, click here) and International Federation of Associations of Pharmaceutical Physicians (IFAPP). The new programme has been re-accredited and updated to reflect current best practice in the science of Pharmaceutical Medicine drug development.
For eligible candidates, it is the ideal preparation for the Faculty of Pharmaceutical Medicine (FPM) Diploma in Pharmaceutical Medicine from the Royal Colleges of Physicians in the United Kingdom. Since the curriculum is accredited by IFAPP it mirrors the FPM curriculum.
Eligible graduates of the programme have also been awarded the DGPharMed, from the Deutsche Gesellschaft für Pharmazeutische Medizin.
